secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arch Therapeutics, Inc. (—)
CIK:        0001537561
Form:       8-K
Filed at:   2024-04-03T23:59:59+00:00
Accession:  0001437749-24-010908
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Arch Therapeutics receives $250K advance; warrants triggered if closing delayed or Nasdaq listing not obtained
--------------------------------------------------------------------------------

- Advance of $250,000 as partial prepayment of SPA purchase price on March 28, 2024.
- If closing not by April 30, 2024, purchasers may take 484,963 pre-funded warrants at $0.5155 and 484,963 common warrants.
- If Nasdaq listing not approved by April 30, 2024, additional 121,240 pre-funded warrants and 121,240 common warrants by May 2, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1537561/000143774924010908/0001437749-24-010908-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1537561/000143774924010908/arch20240403_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-010908

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer